ConductScience.org, home

Paper11297486

Risk factors for age-related macular degeneration: Pooled findings from three continents.

Smith W and 9 others. Ophthalmology, 2001. Cited by 825 papers, by iCite.

Cite this record

ConductScience Library. Risk factors for age-related macular degeneration: Pooled findings from three continents. Papers, record 11297486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11297486

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Risk factors for age-related macular degeneration: Pooled findings from three continents.
PubMed
Journal
Ophthalmology
PubMed
Year
2001
PubMed
Publication types
Journal Article, Meta-Analysis
PubMed
Citations, by iCite
825
iCite
Relative citation ratio, by iCite
21.9
iCite
Revised in PubMed
2022-03-21
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Smith WW
2Assink JJ
3Klein RR
4Mitchell PP
5Klaver CCC C
6Klein BEB E
7Hofman AA
8Jensen SS
9Wang JJJ J
10de Jong PTP T

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Macular DegenerationMajor topic
Adult
Age Distribution
Aged
Aged, 80 and over
Female
Humans
Male
Middle Aged
Netherlands
New South Wales
Prevalence
Risk Factors
Sex Distribution
Smoking
Wisconsin

Source PubMed

Download CSV of topics

Trials3

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT02810808Safety and Efficacy of Two Regimens of Ranibizumab 0.5 mg in Chinese Patients With Neovascular AMDBackgroundClinicalTrials.gov
NCT03326401The Potential Role of Dietary Antioxidant Capacity on Age-Related Macular DegenerationResultsClinicalTrials.gov
NCT05269966Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)ResultsClinicalTrials.gov

Download CSV of trials

Cited by418

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 825 citations.

PMIDTitleJournalYearIn PapersSource
42706530Retinal and choroidal morphometric analysis in fellow eye of unilateral wet age related macular degeneration using optical coherence tomography angiography.BMC Ophthalmol2026https://conductscience.org/library/papers/42706530PubMed
42332292Impaired Rod-Mediated Vision is the Functional Hallmark of Ageing and Early and Intermediate Age-Related Macular Degeneration.Ophthalmic Physiol Opt2026https://conductscience.org/library/papers/42332292PubMed
42222588Geographic Atrophy in Patients with Age-Related Macular Degeneration Is Associated with Rare Variants in Complement Factor H and Complement Factor I.Ophthalmol Sci2026https://conductscience.org/library/papers/42222588PubMed
42196841The Role of Kynurenine and 5-Hydroxytryptophan in Modulating Microbiota and Their Implications in Exudative Age-Related Macular Degeneration.Diagnostics (Basel)2026https://conductscience.org/library/papers/42196841PubMed
42081160The aging eye: navigating molecular mechanisms and innovative interventions.Biogerontology2026https://conductscience.org/library/papers/42081160PubMed
42022797Frequency and comorbidities of age-related macular degeneration in KSA: A retrospective multiregional study.J Taibah Univ Med Sci2026https://conductscience.org/library/papers/42022797PubMed
41896965Simulation of prosthetic vision with the PRIMA system and enhancement of face representation.J Neuroeng Rehabil2026https://conductscience.org/library/papers/41896965PubMed
41794975Integrating genetics, age and imaging to predict treatment outcomes in neovascular age-related macular degeneration: a proof-of-concept study.Sci Rep2026https://conductscience.org/library/papers/41794975PubMed
41790719Efficacy of a single dose switch from aflibercept to ranibizumab in the treatment of neovascular age-related macular degeneration.PLoS One2026https://conductscience.org/library/papers/41790719PubMed
41684578Age-related macular degeneration in the context of an update from the Global Burden of Disease Study 2019.Arch Med Sci2025https://conductscience.org/library/papers/41684578PubMed
41222198Disease Progression in Age-Related Macular Degeneration Patients Carrying Rare Variants in the Complement Factor H or Complement Factor I Genes.Invest Ophthalmol Vis Sci2025https://conductscience.org/library/papers/41222198PubMed
41181297Markedly Lower Rates of Age-Related Macular Degeneration in Malta Compared to European Countries: Results from The Malta Eye Study, Indicating Possible Divergent Genetic Ancestry?Clin Ophthalmol2025https://conductscience.org/library/papers/41181297PubMed
41177553Comparative outcomes of aflibercept biosimilars and reference aflibercept in nAMD: a systematic review and meta-analysis.BMJ Open Ophthalmol2025https://conductscience.org/library/papers/41177553PubMed
41160616Association of perchlorate, nitrate, and thiocyanate with age-related macular degeneration in the United States.PLoS One2025https://conductscience.org/library/papers/41160616PubMed
41055418Perceptual learning of prosthetic vision using video game training.J Vis2025https://conductscience.org/library/papers/41055418PubMed
40960227Reshaping the Burden of nAMD: National, Regional, and Global Prevalence of MNV3 and Its Correlation With Life Expectancy-The RAP Study, Report 7.Invest Ophthalmol Vis Sci2025https://conductscience.org/library/papers/40960227PubMed
40925399Amorphous silicon resistors enable smaller pixels in photovoltaic retinal prosthesis.J Neural Eng2025https://conductscience.org/library/papers/40925399PubMed
40806731Epigenetic Alterations in Age-Related Macular Degeneration: Mechanisms and Implications.Int J Mol Sci2025https://conductscience.org/library/papers/40806731PubMed
40794636Unveiling the drivers of geographic atrophy progression in eyes with reticular pseudodrusen.PLoS One2025https://conductscience.org/library/papers/40794636PubMed
40781266Association between age-related macular degeneration and osteoporosis in US.Sci Rep2025https://conductscience.org/library/papers/40781266PubMed

See all 418 cited byDownload CSV of cited by

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
BROLUCIZUMABCHEMBL3707357Results1https://conductscience.org/library/drugs/CHEMBL3707357

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11297486

GET https://conductscience.org/api/papers/v1/11297486/cited_by?page=2